Annual Report 2025
Key Figures – Group
-
Group Sales
€ 45.6 bn
Fx & p adj. +1.1%
-
EBITDA Before Special Items
€ 9.7 bn
–4.5%
-
Core Earnings per Share
€ 4.91
–2.8%
-
Net Income
–€ 3.6 bn
-
Free Cash Flow
€ 2.1 bn
–32.9%
-
Net Financial Debt
€ 29.8 bn
–8.5%
-
Dividend per Share
€ 0.11
-
Group Sales
€ 45.6 bn
Fx & p adj. +1.1%
-
Core Earnings per Share
€ 4.91
–2.8%
-
Free Cash Flow
€ 2.1 bn
–32.9%
-
Dividend per Share
€ 0.11
-
EBITDA Before Special Items
€ 9.7 bn
–4.5%
-
Net Income
–€ 3.6 bn
-
Net Financial Debt
€ 29.8 bn
–8.5%
Chairman’s Message
“Last year tested us. And Team Bayer was up to the task. In July, we raised our guidance and we hit our upgraded targets.”
Key Figures – Divisions
-
Sales
€ 21.6 bn
Fx & p adj. +1.1%
-
EBITDA Before Special Items
€ 4.2 bn
–3.2%
-
Sales
€ 17.8 bn
Fx & p adj. +1.7%
-
EBITDA Before Special Items
€ 4.5 bn
–4.2%
-
Sales
€ 5.8 bn
Fx & p adj. –0.1%
-
EBITDA Before Special Items
€ 1.3 bn
–1.8%
